RHUMBLINE ADVISERS - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 201 filers reported holding HERON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,243
-12.6%
135,202
-1.6%
0.00%
Q2 2023$159,404
+77280.6%
137,418
+0.7%
0.00%
Q1 2023$206
-38.0%
136,445
+2.7%
0.00%
Q4 2022$332
-99.9%
132,887
+2.8%
0.00%
-100.0%
Q3 2022$545,000
+61.7%
129,259
+7.0%
0.00%
Q2 2022$337,000
-41.8%
120,787
+19.3%
0.00%
-100.0%
Q1 2022$579,000
-38.5%
101,284
-1.8%
0.00%0.0%
Q4 2021$941,000
-16.2%
103,098
-1.8%
0.00%
-50.0%
Q3 2021$1,123,000
-28.2%
105,039
+4.2%
0.00%0.0%
Q2 2021$1,565,000
-7.9%
100,829
-3.9%
0.00%0.0%
Q1 2021$1,700,000
-30.2%
104,876
-8.8%
0.00%
-33.3%
Q4 2020$2,435,000
+43.1%
115,038
+0.2%
0.00%0.0%
Q3 2020$1,702,000
-14.2%
114,862
-14.8%
0.00%0.0%
Q2 2020$1,983,000
+43.5%
134,826
+14.5%
0.00%0.0%
Q1 2020$1,382,000
-48.1%
117,716
+4.0%
0.00%
-25.0%
Q4 2019$2,661,000
+42.7%
113,227
+12.3%
0.00%
+33.3%
Q3 2019$1,865,000
+0.6%
100,802
+1.1%
0.00%0.0%
Q2 2019$1,853,000
-14.4%
99,678
+12.5%
0.00%
-25.0%
Q1 2019$2,165,000
-6.8%
88,585
-1.1%
0.00%
-20.0%
Q4 2018$2,323,000
+24.8%
89,541
+52.2%
0.01%
+25.0%
Q3 2018$1,862,000
-19.3%
58,829
-1.0%
0.00%
-20.0%
Q2 2018$2,308,000
+69.8%
59,401
+20.7%
0.01%
+66.7%
Q1 2018$1,359,000
+74.9%
49,228
+14.7%
0.00%
+50.0%
Q4 2017$777,000
-5.9%
42,906
-16.1%
0.00%0.0%
Q3 2017$826,000
+17.8%
51,120
+1.0%
0.00%0.0%
Q2 2017$701,000
+5.3%
50,630
+14.1%
0.00%0.0%
Q1 2017$666,000
+47.0%
44,381
+28.3%
0.00%
+100.0%
Q4 2016$453,000
-25.9%
34,603
-2.4%
0.00%
-50.0%
Q3 2016$611,000
-3.8%
35,466
+0.8%
0.00%0.0%
Q2 2016$635,000
+14.8%
35,201
+20.8%
0.00%0.0%
Q1 2016$553,000
-28.7%
29,134
+0.3%
0.00%0.0%
Q4 2015$776,000
+20.9%
29,054
+10.4%
0.00%0.0%
Q3 2015$642,000
-4.6%
26,319
+21.9%
0.00%0.0%
Q2 2015$673,000
+116.4%
21,585
+1.1%
0.00%
+100.0%
Q1 2015$311,000
+88.5%
21,350
+29.8%
0.00%
Q4 2014$165,000
+25.0%
16,450
+3.6%
0.00%
Q3 2014$132,000
-23.3%
15,875
+13.8%
0.00%
-100.0%
Q2 2014$172,00013,9500.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders